The New Era For In Vivo Immunotherapy Testing Is Here
Immunomodulatory therapies are the latest weapon to be added to the cancer-fighting arsenal. These therapies work by generating or augmenting the immune response to a tumor. Discovering and validating these candidates has been both time-consuming and somewhat tricky. The Jackson Laboratory, the leader in cutting-edge in vivo studies and efficacy testing, reveals the latest in vivo platform to test and validate immunotherapeutic candidates.